RAB23 regulates musculoskeletal development and patterning

Front Cell Dev Biol. 2023 Feb 23:11:1049131. doi: 10.3389/fcell.2023.1049131. eCollection 2023.

Abstract

RAB23 is a small GTPase which functions at the plasma membrane to regulate growth factor signaling. Mutations in RAB23 cause Carpenter syndrome, a condition that affects normal organogenesis and patterning. In this study, we investigate the role of RAB23 in musculoskeletal development and show that it is required for patella bone formation and for the maintenance of tendon progenitors. The patella is the largest sesamoid bone in mammals and plays a critical role during movement by providing structural and mechanical support to the knee. Rab23 -/- mice fail to form a patella and normal knee joint. The patella is formed from Sox9 and scleraxis (Scx) double-positive chondroprogenitor cells. We show that RAB23 is required for the specification of SOX9 and scleraxis double-positive patella chondroprogenitors during the formation of patella anlagen and the subsequent establishment of patellofemoral joint. We find that scleraxis and SOX9 expression are disrupted in Rab23 -/- mice, and as a result, development of the quadriceps tendons, cruciate ligaments, patella tendons, and entheses is either abnormal or lost. TGFβ-BMP signaling is known to regulate patella initiation and patella progenitor differentiation and growth. We find that the expression of TGFβR2, BMPR1, BMP4, and pSmad are barely detectable in the future patella site and in the rudimentary tendons and ligaments around the patellofemoral joint in Rab23 -/- mice. Also, we show that GLI1, SOX9, and scleraxis, which regulate entheses establishment and maturation, are weakly expressed in Rab23 -/- mice. Further analysis of the skeletal phenotype of Rab23 -/- mice showed a close resemblance to that of Tgfβ2 -/- mice, highlighting a possible role for RAB23 in regulating TGFβ superfamily signaling.

Keywords: GLI1; RAB23; TGFβ2; knee; patella; scleraxis; tenogenesis.

Grants and funding

This work was supported by the Academy of Finland (to DR257472), Biocentrum Helsinki, Research Foundation of Helsinki University Hospital (to DR TYH2015319), FINDOS-Helsinki, and Sigrid Jusélius Foundation (4702957 to DR and 47300061 to SJB).